CIB vs BMA

For growth investors, Grupo Cibest S.

A. (CIB) is the stronger pick with 0. 0% revenue growth year-over-year, versus -33. 3% for Banco Macro S. A. (BMA). Grupo Cibest S. A. (CIB) offers the better valuation at 8. 7x trailing P/E (0. 0x forward), making it the more compelling value choice. Analysts rate Grupo Cibest S. A. (CIB) a "Buy" — based on 15 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Grupo Cibest S.

A. (CIB) is the cheapest at 8. 7x versus Banco Macro S. A. at 21. 1x. On forward P/E, Grupo Cibest S. A. is actually cheaper at 0. 0x.

Over the past 5 years, Banco Macro S.

A. (BMA) delivered a total return of +594. 5%, compared to +170. 0% for Grupo Cibest S. A. (CIB). Over 10 years, the gap is even starker: CIB returned +147. 5% versus BMA's +56. 3%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Grupo Cibest S.

A. (CIB) is the lower-risk stock at 0. 69β versus Banco Macro S. A. 's 1. 76β — meaning BMA is approximately 154% more volatile than CIB relative to the S&P 500. On balance sheet safety, Banco Macro S. A. (BMA) carries a lower debt/equity ratio of 11% versus 47% for Grupo Cibest S. A. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Grupo Cibest S.

A. (CIB) is pulling ahead at 0. 0% versus -33. 3% for Banco Macro S. A. (BMA). On earnings-per-share growth, the picture is similar: Grupo Cibest S. A. grew EPS 9. 2% year-over-year, compared to -44. 6% for Banco Macro S. A.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Grupo Cibest S.

A. (CIB) is the more profitable company, earning 15. 8% net margin versus 5. 0% for Banco Macro S. A. — meaning it keeps 15. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CIB leads at 20. 8% versus 5. 6% for BMA. At the gross margin level — before operating expenses — BMA leads at 68. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, Grupo Cibest S.

A. (CIB) trades at 0. 0x forward P/E versus 0. 0x for Banco Macro S. A. — 0. 0x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for BMA: 68. 9% to $130. 00.

All stocks in this comparison pay dividends.

Grupo Cibest S. A. (CIB) offers the highest yield at 8. 8%, versus 6. 8% for Banco Macro S. A. (BMA).

For long-horizon retirement investors, Grupo Cibest S.

A. (CIB) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 69), 8. 8% yield, +147. 5% 10Y return). Banco Macro S. A. (BMA) carries a higher beta of 1. 76 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (CIB: +147. 5%, BMA: +56. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: CIB is a mid-cap deep-value stock; BMA is a small-cap income-oriented stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.